Brief: Prime Medicine And Myeloid Therapeutics Announce Settlement Of Pending Disputes
05/01/2024 22:30
Jan 5 (Reuters) - Prime Medicine Inc PRME.O :
* PRIME MEDICINE AND MYELOID THERAPEUTICS ANNOUNCE
SETTLEMENT OF
PENDING DISPUTES
Source text for Eikon: ID:nPnQX6kca
Further company coverage: PRME.O
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease